Literature DB >> 22703878

Familial pityriasis rubra pilaris is caused by mutations in CARD14.

Dana Fuchs-Telem1, Ofer Sarig, Maurice A M van Steensel, Ofer Isakov, Shirli Israeli, Janna Nousbeck, Katharina Richard, Veronique Winnepenninckx, Marigje Vernooij, Noam Shomron, Jouni Uitto, Philip Fleckman, Gabriele Richard, Eli Sprecher.   

Abstract

Pityriasis rubra pilaris (PRP) is a papulosquamous disorder phenotypically related to psoriasis. The disease has been occasionally shown to be inherited in an autosomal-dominant fashion. To identify the genetic cause of familial PRP, we ascertained four unrelated families affected by autosomal-dominant PRP. We initially mapped PRP to 17q25.3, a region overlapping with psoriasis susceptibility locus 2 (PSORS2 [MIM 602723]). Using a combination of linkage analysis followed by targeted whole-exome sequencing and candidate-gene screening, we identified three different heterozygous mutations in CARD14, which encodes caspase recruitment domain family, member 14. CARD14 was found to be specifically expressed in the skin. CARD14 is a known activator of nuclear factor kappa B signaling, which has been implicated in inflammatory disorders. Accordingly, CARD14 levels were increased, and p65 was found to be activated in the skin of PRP-affected individuals. The present data demonstrate that autosomal-dominant PRP is allelic to familial psoriasis, which was recently shown to also be caused by mutations in CARD14.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22703878      PMCID: PMC3397268          DOI: 10.1016/j.ajhg.2012.05.010

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  37 in total

1.  Pityriasis rubra pilaris in a patient with human immunodeficiency virus infection.

Authors:  N Auffret; L Quint; P Domart; L Dubertret; J Y Lecam; O Binet
Journal:  J Am Acad Dermatol       Date:  1992-08       Impact factor: 11.527

2.  Pityriasis rubra pilaris in a child seropositive for the human immunodeficiency virus.

Authors:  S Menni; W Brancaleone; R Grimalt
Journal:  J Am Acad Dermatol       Date:  1992-12       Impact factor: 11.527

3.  Pityriasis rubra pilaris: the problem of its classification.

Authors:  W A Griffiths
Journal:  J Am Acad Dermatol       Date:  1992-01       Impact factor: 11.527

4.  Pityriasis rubra pilaris, a familial condition.

Authors:  A Kint; S De Bie; M L Geerts; R T'Kint
Journal:  Arch Belg Dermatol Syphiligr       Date:  1972 Oct-Dec

5.  Pityriasis rubra pilaris and human immunodeficiency virus infection--type 6 pityriasis rubra pilaris?

Authors:  I Misery; M Faure; A Claidy
Journal:  Br J Dermatol       Date:  1996-12       Impact factor: 9.302

6.  Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.

Authors:  Catherine T Jordan; Li Cao; Elisha D O Roberson; Shenghui Duan; Cynthia A Helms; Rajan P Nair; Kristina Callis Duffin; Philip E Stuart; David Goldgar; Genki Hayashi; Emily H Olfson; Bing-Jian Feng; Clive R Pullinger; John P Kane; Carol A Wise; Raphaela Goldbach-Mansky; Michelle A Lowes; Lynette Peddle; Vinod Chandran; Wilson Liao; Proton Rahman; Gerald G Krueger; Dafna Gladman; James T Elder; Alan Menter; Anne M Bowcock
Journal:  Am J Hum Genet       Date:  2012-04-19       Impact factor: 11.025

7.  Histologic criteria for the diagnosis of pityriasis rubra pilaris.

Authors:  F F Soeprono
Journal:  Am J Dermatopathol       Date:  1986-08       Impact factor: 1.533

8.  Pityriasis rubra pilaris: a clinico-pathological and therapeutic study with special reference to histochemistry, autoradiography, and electron microscopy.

Authors:  O Braun-Falco; F Ryckmanns; C Schmoeckel; M Landthaler
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 9.  Pityriasis rubra pilaris and human immunodeficiency virus infection.

Authors:  E S Miralles; M Núñez; M E De Las Heras; B Pérez; R Moreno; A Ledo
Journal:  Br J Dermatol       Date:  1995-12       Impact factor: 9.302

10.  Familial pityriasis rubra pilaris.

Authors:  S L Vanderhooft; J S Francis; K A Holbrook; B A Dale; P Fleckman
Journal:  Arch Dermatol       Date:  1995-04
View more
  60 in total

Review 1.  Genetically defined autoinflammatory diseases.

Authors:  A A de Jesus; R Goldbach-Mansky
Journal:  Oral Dis       Date:  2016-04-14       Impact factor: 3.511

Review 2.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

Authors:  Qian Zhang; Michael J Lenardo; David Baltimore
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

Review 3.  Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.

Authors:  Gina A Montealegre Sanchez; Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Rheum Dis Clin North Am       Date:  2013-09-21       Impact factor: 2.670

Review 4.  Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.

Authors:  Bertrand Boisson; Pierre Quartier; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2015-01-31       Impact factor: 7.486

Review 5.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

6.  The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.

Authors:  Inna S Afonina; Elien Van Nuffel; Griet Baudelet; Yasmine Driege; Marja Kreike; Jens Staal; Rudi Beyaert
Journal:  EMBO Rep       Date:  2016-04-25       Impact factor: 8.807

Review 7.  Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.

Authors:  Yvan Jamilloux; Alexandre Belot; Flora Magnotti; Sarah Benezech; Mathieu Gerfaud-Valentin; Emilie Bourdonnay; Thierry Walzer; Pascal Sève; Thomas Henry
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 8.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

9.  Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.

Authors:  Dylan Haynes; Jennifer L Strunck; Christina A Topham; Alex G Ortega-Loayza; Gail Kent; Pamela B Cassidy; Ronghua Hu; Keith Choate; Zhiping Wang; Yuangang Liu; Teri M Greiling
Journal:  JAMA Dermatol       Date:  2020-06-01       Impact factor: 10.282

Review 10.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.